![David Lechuga-Ballesteros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Lechuga-Ballesteros
Corporate Officer/Principal presso
University of Connecticut
Profilo
Dr. David Lechuga-Ballesteros is Senior Director-Research & Development at Aridis Pharmaceuticals, Inc. and a Faculty Member at University of Connecticut.
Dr. Lechuga-Ballesteros was previously employed as a Principal by Nektar Therapeutics.
He received his doctorate degree from the University of Michigan.
Posizioni attive di David Lechuga-Ballesteros
| Società | Posizione | Inizio |
|---|---|---|
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 12/08/2009 |
Precedenti posizioni note di David Lechuga-Ballesteros
| Società | Posizione | Fine |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
| ARIDIS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di David Lechuga-Ballesteros
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
31
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aridis Pharmaceuticals, Inc.
 Aridis Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for infectious diseases | Health Technology |
